AOXG (Aoxing Pharmaceutical Co) EBITDA Margin %: 19.66% (As of Mar. 2017)


What is Aoxing Pharmaceutical Co EBITDA Margin %?

Aoxing Pharmaceutical Co AOXG EBITDA Margin % is 19.66% as of Mar. 2017.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aoxing Pharmaceutical Co's EBITDA for the three months ended in Mar. 2017 was $1.12 Mil. Aoxing Pharmaceutical Co's Revenue for the three months ended in Mar. 2017 was $5.70 Mil. Therefore, Aoxing Pharmaceutical Co's EBITDA margin for the quarter that ended in Mar. 2017 was 19.66%.

Aoxing Pharmaceutical Co  (OTCPK:AOXG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Aoxing Pharmaceutical Co EBITDA Margin % Related Terms

Aoxing Pharmaceutical Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co EBITDA Margin % Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.86 -50.18 -18.41 36.74 22.44

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.07 -18.14 25.74 6.28 19.66

AOXG vs OWCP, BSPK, MYHI: EBITDA Margin % Comparison

For the Shell Companies subindustry, Aoxing Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aoxing Pharmaceutical Co EBITDA Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Aoxing Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's EBITDA Margin % falls into.


Aoxing Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aoxing Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Jun. 2016 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2016 )/Revenue (A: Jun. 2016 )
=7.254/32.33
=22.44 %

Aoxing Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Mar. 2017 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2017 )/Revenue (Q: Mar. 2017 )
=1.121/5.702
=19.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 19.66% mean?
Aoxing Pharmaceutical Co (AOXG) has a EBITDA Margin % of 19.66% as of Mar. 2017. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aoxing Pharmaceutical Co and its competitors.
Is Aoxing Pharmaceutical Co's EBITDA Margin % too high?
Aoxing Pharmaceutical Co's current EBITDA Margin % is 19.66%. The Diversified Financial Services industry median EBITDA Margin % is 11.57. Aoxing Pharmaceutical Co's value of 19.66% is 70% above this industry median.
How does Aoxing Pharmaceutical Co's EBITDA Margin % compare to OWCP and BSPK?
Aoxing Pharmaceutical Co's EBITDA Margin % of 19.66% can be compared against companies in the Diversified Financial Services industry. The industry median EBITDA Margin % is 11.57. Aoxing Pharmaceutical Co's value of 19.66% is 70% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Diversified Financial Services company?
The median EBITDA Margin % among Diversified Financial Services companies is 11.57, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aoxing Pharmaceutical Co's current EBITDA Margin % of 19.66% is 70% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aoxing Pharmaceutical Co and its competitors. For the Diversified Financial Services industry, the median EBITDA Margin % is 11.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxing Pharmaceutical Co's current EBITDA Margin % is 19.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxing Pharmaceutical Co stock overvalued right now?
Aoxing Pharmaceutical Co (AOXG) has a current EBITDA Margin % of 19.66%. The current EBITDA Margin % is 19.66% and 70% above the Diversified Financial Services industry median of 11.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aoxing Pharmaceutical Co (AOXG), the current EBITDA Margin % is 19.66% as of Mar. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.